2522 Stock Overview
Operates medical imaging centers in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Jiangxi Rimag Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$50.45 |
| 52 Week High | HK$50.90 |
| 52 Week Low | HK$13.50 |
| Beta | 0 |
| 11 Month Change | 39.94% |
| 3 Month Change | 175.68% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 236.33% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2522 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | 8.7% | -1.5% | -0.6% |
| 1Y | n/a | -27.6% | 9.6% |
Return vs Industry: Insufficient data to determine how 2522 performed against the Hong Kong Healthcare industry.
Return vs Market: Insufficient data to determine how 2522 performed against the Hong Kong Market.
Price Volatility
| 2522 volatility | |
|---|---|
| 2522 Average Weekly Movement | 9.7% |
| Healthcare Industry Average Movement | 7.9% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in HK Market | 19.0% |
| 10% least volatile stocks in HK Market | 4.2% |
Stable Share Price: 2522 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: Insufficient data to determine 2522's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 1,667 | Zhaoyang Chen | www.rimag.com.cn |
Jiangxi Rimag Group Co., Ltd. operates medical imaging centers in China. The company offers imaging examination and diagnostic service, such as MRI, CT, PET, X-ray, ultrasound, and mammography to patients and other healthcare consumers; imaging solution services; and Rimag Cloud services, including cloud storage and cloud film module services, cloud radiology information system services, cloud Picture Archive and Communication System services, and imaging AI integration platform modules and operational management modules. It also operates and manages medical imaging platform that provides diversified imaging services; research and development center; and sells medical equipment and consumables.
Jiangxi Rimag Group Co., Ltd. Fundamentals Summary
| 2522 fundamental statistics | |
|---|---|
| Market cap | HK$17.98b |
| Earnings (TTM) | HK$5.66m |
| Revenue (TTM) | HK$873.29m |
3,174x
P/E Ratio20.6x
P/S RatioIs 2522 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2522 income statement (TTM) | |
|---|---|
| Revenue | CN¥812.85m |
| Cost of Revenue | CN¥509.22m |
| Gross Profit | CN¥303.63m |
| Other Expenses | CN¥298.35m |
| Earnings | CN¥5.27m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.015 |
| Gross Margin | 37.35% |
| Net Profit Margin | 0.65% |
| Debt/Equity Ratio | 17.0% |
How did 2522 perform over the long term?
See historical performance and comparison